MetaCap

Phathom Pharmaceuticals Statistics

NASDAQ: PHATHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.66-0.42 (-8.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Phathom Pharmaceuticals by the numbers

Phathom Pharmaceuticals has a market capitalization of $378.8 million based on 81.29M shares outstanding. With trailing EPS of $-1.01, Phathom Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.5% below its 50-day average and 52.6% below its 200-day average.

Average daily trading volume is 1.45M shares, or about $6.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PHAT valuation vs. peer median

PHAT compared with the median of 8 peer companies
MetricPHATPeer medianDifference
Market cap$378.82M$375.06M+1%
Avg. volume1.45M1.29M+13%

Peer median across 8 companies: IRD, AVTX, PBYI, OCS, ASPE, PEPG, OVID, CTNM.

Valuation

Market cap
$378.82M
Price / sales (latest FY)
2.16
EPS (TTM)
$-1.01

Price and trading

Previous close
5.08
Open
5.03
Day range
4.62 – 5.15
52-week range
4.62 – 18.31
52-week change
-68.93%
Beta
—
Volume
1.33M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
378.82M
Forward Pe
5.18
Eps
-1.01
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
18.31
Week52 Low
4.62
Avg Volume
1.45M
Shares Outstanding
81.29M
Ma50
6.61
Ma200
9.82
Earnings Date
Oct 29, 2026
Pct From52w High
-74.55%
Pct From52w Low
0.98%

Related